Scientific Excellence in Consumer Safety
Science-Based Decision-Making Workshop
Biographies
Chairman: Howard Chase
Howard Chase is the Chairman of the European Regulation and Innovation Forum (ERIF). He has been Senior Advisor to the Chief Executive of Dow based at the Dow Europe, Middle East, Africa and India (EMEAI) regional headquarters in Horgen, Switzerland. In that position, he has advised on major public policy and government relations issues of strategic importance for the company. These include energy and carbon policy, trade policy, plastics and the circular economy, chemicals regulation, industrial policy and political and geopolitical risk.
Prior to joining Dow, Mr. Chase held senior Government Affairs posts for BP plc in Brussels, Washington DC, Moscow and London and undertook various assignments in Azerbaijan, Georgia, Turkey, Angola, Algeria, Colombia, Vietnam and other locations worldwide.
Mr. Chase studied at Cambridge University in the UK and at Harvard Business School.
Amongst various external and industry roles, Mr. Chase is a former Chairman of the Industry Advisory Panel of the Energy Charter Treaty (ECT) and served on the European Commission High Level Group on Competitiveness, Energy and the Environment.
Moderator: Dirk Hudig
Dirk Hudig is the Secretary General of the European Regulation and Innovation Forum (ERIF). He was Secretary General of the Union of Industrial & Employers' Confederations of Europe (UNICE, now BusinessEurope) from 1998 to 2001, having previously chaired UNICE's Committee on State Aid.
Mr. Hudig has held several other posts including Chairman of the BIAC Environment Committee in the OECD, Secretary and later Treasurer of the Society of Chemical Industry Europe Committee, and sat on the Transatlantic Policy Network (TPN) Programme Committee. Mr. Hudig is also a former President of the British Chamber of Commerce and was honoured with an OBE by the British Government for this. He joined ICI, the UK Chemicals company, in 1970 and worked in various businesses within the group in Rotterdam, London & Brussels before becoming national Head and Group Manager of EU Government Relations for ICI from 1987-1998.
Sir Colin Berry
Sir Colin Berry is a former head of Department and Professor of Pathology at the Royal London Hospital. He has a body of experimental work in development and vascular pathology but his interest in toxicology has meant that he has served as a member of the Committee on Safety of Medicines and as a member of a number of other related committees of the European Commission. He was Chairman of the UK Advisory Committee on Pesticides for 10 years.
Sir Colin is a former member of the Medical Research Council of Great Britain and has remained an advisor to that body. He is a former President of the European Society of Pathology and of the British Academy of Forensic Sciences. He was elected to the German Academy of Sciences (Deutsche Akademie der Natureforscher Leopoldina) in 1993 and made Knight Bachelor in the Queen's Birthday Honours List in the same year, for services to Medicine and Science. He is an Honorary Fellow of the Royal Colleges of Physicians of both London and Edinburgh, of the Faculty of Occupational Medicine, the Faculty of Pharmaceutical Medicine and has a number of honorary degrees from overseas universities.
He is currently involved in work on the public understanding of science and served on the Steering Committee of the European Science Open Forum and is a former Chairman of its programme committee. He is on the management board of Sense about Science, a body that advises opinion formers about the consequences of scientific legislation. He is a former Honorary Curator of the Deutsches Museum in Munich.
In 2005 he was made an Honorary Fellow of the German Pathological Society and of the British Society of Toxicology. More recently he has been awarded the International Achievement award of the Society of Regulatory Toxicology and Pharmacology for 2021.
Karl-Heinz Jöckel
Karl-Heinz Jöckel is Professor of Medical Informatics, Biometry, and Epidemiology and has been the Managing Director of the Institute for Medical Informatics, Biometry and Epidemiology at the Essen University Medical Center since 1994.
He was also Vice-Rector for Quality Management at the University of GH Essen (2001–2002), Rector of the University of GH Essen (2002) and Deanof the Medical Faculty of the University of Duisburg-Essen in two terms of office (2004–2008). Since 2006 he has been the chairman of the Essen University Medicine Foundation. Between 2012 and 2017 he was chairman of the National Cohort eV.
In 2018, Clarivate Analytics ranked him among the 1% most cited scientists.
Professor Jöckel is or was a member of numerous specialist societies and expert committees, including chairman of the Joint Scientific Advisory Board (GWB) of the Federal Ministry of Health. He is currently a member of the Radiation Protection Commission (SSK) and the Medical Expert Group for Occupational Diseases.
Daniel Dietrich
Daniel Dietrich is Full Professor of Toxicology, Head of Human and Environmental Toxicology at the University of Konstanz (Germany) since 1996, where he is also the Dean of Studies and the Head of the Board of Examinations of the Faculty of Biology.
Professor Dietrich studied biochemistry and biology with focus on toxicology at the University of Zurich and the ETH Zurich, Switzerland. He completed his PhD. at the Institute of Toxicology of the ETHZ in Zurich Switzerland. During his post-doc (1989-1991) he worked for the Chemical Industries Institute of Toxicology (CIIT), Glaxo Research Laboratories, and the University of North Caroline at Chapel Hill, North Carolina, USA, where he focused on molecular aspects of renal cancer development and extrapolation in human risk assessment. Subsequently he returned to the ETHZ Institute of Toxicology where he supervised the ecotoxicology research group. In September 1994 he received the venia legendi in toxicology and then moved to the University of Pittsburgh, Department of Environmental and Occupational Health as an associate professor.
Amongst many international activities (e.g. Chair, Co-Chair and expert for DG-SANCO, ECVAM, OECD VMG-NA, US-EPA, EC-SAM, EC-SAPEA, PEPPER, elected external expert „Life Sciences for human well-being“ for the European Parliament, etc.) he was co-founder of the European IMI-JU funded SafeSciMET Program in 2010 and since then coordinates the continuing education courses offered in the quest of promoting better trained toxicologist and safety scientist. With more than 200 publications, he is the Editor-in-Chief of Chemico Biological Interactions and Computational Toxicology.
Paul Carmichael
Paul Carmichael is an Endowed Professor at Wageningen University, Division of Toxicology in the Netherlands since 2020. He has worked in the Safety & Environmental Assurance Centre (SEAC) of Unilever in the UK since 2004, where he is responsible for the development and implementation of novel non-animal-based approaches for assuring human and environmental health; that is to say, how can consumer and environmental safety be assured without using and harming animals? He has over thirty years’ experience in toxicology and cancer research, largely in the academic arena, and prior to Unilever, he was a Senior Lecturer at Imperial College London in the Faculty of Medicine, where he taught pharmacology and toxicology and conducted research into advances in toxicology.
A graduate of Surrey University with a B.Sc. in Biochemistry/Toxicology and a Ph.D. from King’s College London, he was a postdoctoral scientist at the Institute of Cancer Research (Royal Marsden Hospital) for seven years, exploring mechanisms of chemical genotoxicity and carcinogenicity. He currently has close academic links with Peking University in China (the School of Public Health) and is an Adjunct Assistant Professor of Pathology and Laboratory Medicine at Brown University in the USA.
Professor Carmichael has published over one hundred research papers in peer-reviewed scientific journals and has served or serves on many external committees in the UK, US, EU and China. His passion is the advancement of new safety assessment approaches using the inspiration of ‘Toxicity Testing in the 21st Century’ – this can be termed ‘next generation risk assessments’ or NGRA.
Richard Meads
Richard Meads is the Rapporteur of the European Regulation and Innovation Forum (ERIF).
Mr. Meads has been involved with Better Regulation for over twenty years. He has worked with a number of different think tanks.
As Rapporteur of the ERIF, Mr. Meads has contributed to over 100 articles, papers and studies covering better regulation, science and decision-making, and innovation. A director of Business Decisions Limited for more than twenty-five years, Richard previously worked for British Petroleum in a range of different functions including finance, corporate planning and marketing.
Educated at Oxford University, Mr. Meads is also a Chartered Accountant.
Jim Bridges
Jim Bridges is the Emeritus Professor of Toxicology and Environmental Health at the University of Surrey, UK. His Scientific Advisory Committee (SC’s) activities have included: Chair of the EU CSTEE (Toxicity, Ecotoxicity and the Environment), then the EU SCENHIR (Emerging and Newly Identified Health Risks) for (17 years in toto). He was a member of the EU SSC and led the EU ‘harmonization of risk assessment’ initiative. He was also a member of SC’s for the UK government and for various other organizations (some of which he Chaired), consequently was involved in a very wide range of toxicological issues. He also acted as consultant for many organizations on toxicological and analytical problems.
Professor Bridges is author or co-author of over 500 papers, opinions, and reviews. He was responsible for starting the first MSc in Toxicology in Europe and for initiating the European Drug Metabolism Workshops, the British Toxicology Society and FEST, which evolved to become EUROTOX.
Professor Bridges presently chairs several SC’s for different organizations’ and runs a small company, Research for Sustainability Ltd.
Sue O'Hagan
Sue O’Hagan is Director Scientific Affairs at PepsiCo International based in the UK. She has spent her career working in food toxicology/safety in both Government and Private sector. Her career in toxicology started in the UK Department of Health & the Food Standards Agency. In 2000 she joined Unilever working in a variety of roles, latterly as a Toxicology Expertise Leader at its Safety & Environmental Assurance Centre, before moving to PepsiCo. Dr. O’Hagan has a BSc in Biochemistry from Glasgow University and a Master’s degree in Nutrition from the University of Surrey. She is currently Chair of FoodDrinkEurope’s Science Expert Group.
Angus Cameron
Angus Cameron is a Managing Director at the Biological Consulting Europe Ltd.
He has over 30 years experience in the pharmaceutical field including overall programme management for numerous new products. His regulatory experience covers clinical trial and marketing authorisation applications in both Europe and the USA in a wide range of therapeutic areas. He has extensive experience of interacting with the regulatory agencies.
Mr. Angus now provides expert advice in the areas of non-clinical and clinical development strategies, clinical trial submissions and scientific advice procedures, with particular expertise in the areas of orphan medicines and advanced therapies. He also offers strategic advice to companies involved in drug development and has led on the preparation of development strategies and regulatory submissions to the European and US regulatory agencies.
Mr. Cameron provides training and gives presentations on regulatory affairs topics at symposia and to companies in UK, USA and Japan.
Angus holds a B.Sc. (Biochemistry) and is a Chartered Biologist, Member, Society of Biology and Member of the Organisation for Professionals in Regulatory Affairs.
Return to our main event page